Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Clinical Laboratory Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Diagn Microbiol Infect Dis. 2023 Aug;106(4):115972. doi: 10.1016/j.diagmicrobio.2023.115972. Epub 2023 Apr 29.
To grasp the epidemiological trend and drug resistance mechanisms of Clostridioides difficile (C. diff) in Beijing, 302 C. diff isolates were obtained from patients with diarrhea. The sequence types (STs) from mainstream strains were all susceptible to metronidazole, vancomycin, piperacillin/tazobactam, meropenem, and tigecycline but almost resistant to ciprofloxacin and clindamycin. The missense mutation of GyrA/GyrB and RpoB resulted in fluoroquinolone and rifamycin resistance, respectively. Toxigenic strains from clade IV were likely to be missed due to the deficiency of tcdA gene. Four tcdC genotypes were first detected in strains from clade III and IV. The truncating mutation of TcdC disabled its function working as a toxin suppressor. In conclusion, the molecular epidemiology of C. diff in Beijing is different from other regions of China. The antimicrobial resistance patterns and toxin-producing abilities of strains with different STs varied greatly, which suggests that continuous surveillance and control are meaningful and urgent.
为了掌握北京艰难梭菌(C. diff)的流行病学趋势和耐药机制,从腹泻患者中获得了 302 株艰难梭菌分离株。主流菌株的序列类型(STs)均对甲硝唑、万古霉素、哌拉西林/他唑巴坦、美罗培南和替加环素敏感,但几乎对环丙沙星和克林霉素耐药。GyrA/GyrB 和 RpoB 的错义突变分别导致氟喹诺酮类和利福霉素类耐药。由于 tcdA 基因的缺失,可能会错过 IV 群产毒株。首次在 III 群和 IV 群菌株中检测到 4 种 tcdC 基因型。TcdC 的截断突变使其无法作为毒素抑制剂发挥作用。总之,北京艰难梭菌的分子流行病学与中国其他地区不同。不同 STs 菌株的抗菌药物耐药模式和产毒能力差异很大,这表明持续监测和控制具有重要性和紧迫性。